UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolic reprogramming in macrophage responses

Biomarker research, 2021-01, Vol.9 (1), p.1-1, Article 1

2021

Volltextzugriff (PDF)

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential

Journal of hematology and oncology, 2022-01, Vol.15 (1), p.8-24, Article 8

2022

Volltextzugriff (PDF)

The many substrates and functions of NEDD4-1

Cell death & disease, 2019-12, Vol.10 (12), p.904-12, Article 904

2019

Volltextzugriff (PDF)

RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways

Oncogene, 2022-01, Vol.41 (3), p.400-413

2022

Volltextzugriff (PDF)

NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma

Cell death & disease, 2022-03, Vol.13 (3), p.197-197, Article 197

2022

Volltextzugriff (PDF)

Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS/PI3K/Akt signalling pathway in liver carcinoma

Cancer cell international, 2021-07, Vol.21 (1), p.1-396, Article 396

2021

Volltextzugriff (PDF)

Integrated bioinformatic analysis of HNF1A in human cancers

Journal of international medical research, 2021-03, Vol.49 (3), p.300060521997326-300060521997326

2021

Volltextzugriff (PDF)

How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?

Protein & cell, 2020-12, Vol.11 (12), p.881-893

2020

Volltextzugriff (PDF)

High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myeloma

Journal of Zhejiang University. B. Science, 2022-11, Vol.23 (11), p.968-974

2022

Volltextzugriff (PDF)

CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest

Journal of Zhejiang University. B. Science, 2023-05, Vol.24 (5), p.442-454

2023

Volltextzugriff (PDF)

Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis

Oncoimmunology, 2022-12, Vol.11 (1), p.2057837-2057837

2022

Volltextzugriff (PDF)

Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma

Biomarker research, 2023-03, Vol.11 (1), p.27-27, Article 27

2023

Volltextzugriff (PDF)

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma

Blood cancer journal (New York), 2021-02, Vol.11 (2), p.32-32, Article 32

2021

Volltextzugriff (PDF)

HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair

Journal of experimental & clinical cancer research, 2018-08, Vol.37 (1), p.205-205, Article 205

2018

Volltextzugriff (PDF)

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma

Frontiers in oncology, 2021-07, Vol.11, p.668099-668099

2021

Volltextzugriff (PDF)

Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease

Haematologica (Roma), 2018-08, Vol.103 (8), p.1369-1379

2018

Volltextzugriff (PDF)

Evaluación del quimerismo celular en un modelo de enfermedad aguda de injerto contra huésped establecido en ratones knockout para TLR4

Cirugia y cirujanos, 2023-10, Vol.91 (5)

2023

Volltextzugriff (PDF)

The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China

Frontiers in oncology, 2022-12, Vol.12, p.1084683-1084683

2022

Volltextzugriff (PDF)

Acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration

Therapeutic advances in hematology, 2021-01, Vol.12, p.2040620720976984

2021

Volltextzugriff (PDF)

Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells

Cellular physiology and biochemistry, 2018-01, Vol.48 (2), p.785-800

2018

Volltextzugriff (PDF)

Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China

Frontiers in oncology, 2021-09, Vol.11, p.740715-740715

2021

Volltextzugriff (PDF)

Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China

Frontiers in oncology, 2021-06, Vol.11

2021

Volltextzugriff (PDF)

High-Order Fiber Mode Beam Parameter Optimization for Transport and Rotation of Single Cells

Micromachines (Basel), 2021-02, Vol.12 (2), p.226

2021

Volltextzugriff (PDF)

Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway

Protein & cell, 2018-09, Vol.9 (9), p.770-784

2018

Volltextzugriff (PDF)

Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis

Cancer Immunology, Immunotherapy, 2019-12, Vol.68 (12), p.1971-1978

2019

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Metabolic reprogramming in macrophage responses

RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential

The many substrates and functions of NEDD4-1

RNA demethylase ALKBH5 promotes tumorigenesis in multiple myeloma via TRAF1-mediated activation of NF-κB and MAPK signaling pathways

NEDD4L binds the proteasome and promotes autophagy and bortezomib sensitivity in multiple myeloma

Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS/PI3K/Akt signalling pathway in liver carcinoma

Integrated bioinformatic analysis of HNF1A in human cancers

How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?

High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myeloma

CUDC-101 as a dual-target inhibitor of EGFR and HDAC enhances the anti-myeloma effects of bortezomib by regulating G2/M cell cycle arrest

Myeloma-derived IL-32γ induced PD-L1 expression in macrophages facilitates immune escape via the PFKFB3-JAK1 axis

Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma

Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma

HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair

Multiple Extramedullary-Bone Related and/or Extramedullary Extraosseous Are Independent Poor Prognostic Factors in Patients With Newly Diagnosed Multiple Myeloma

Therapeutic effects of the novel subtype-selective histone deacetylase inhibitor chidamide on myeloma-associated bone disease

Evaluación del quimerismo celular en un modelo de enfermedad aguda de injerto contra huésped establecido en ratones knockout para TLR4

The adverse impact of a gain in chromosome 1q on the prognosis of multiple myeloma treated with bortezomib-based regimens: A retrospective single-center study in China

Acute myeloid leukemia with CPSF6–RARG fusion resembling acute promyelocytic leukemia with extramedullary infiltration

Metformin and FTY720 Synergistically Induce Apoptosis in Multiple Myeloma Cells

Corrigendum: Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China

Different Patient Subgroup Different Maintenance, Proteasome Inhibitors or Immunomodulators Maintenance for Newly Diagnosed Multiple Myeloma: A 7-Year Single-Center Data in China

High-Order Fiber Mode Beam Parameter Optimization for Transport and Rotation of Single Cells

Pirh2 mediates the sensitivity of myeloma cells to bortezomib via canonical NF-κB signaling pathway

Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis

Suchergebnisse filtern